Magnetic resonance imaging of breast lesions - A pathologic correlation

Breast Cancer Research and Treatment

Volumn 103, Issue 1, 2007, Pages 1-10

  Tse, Gary M K ^a   Chaiwun, Benjaporn ^b   Wong, Ka Tak ^a   Yeung, David K ^a   Pang, Amy L M ^a   Tang, Alice P Y ^c   Cheung, Humairah S ^d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c NORTH DISTRICT HOSPITAL   (Hong Kong)

^d INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Breast; Cancer; Magnetic resonance imaging

Indexed keywords

BREAST FIBROADENOMA; BREAST LESION; CANCER CYTODIAGNOSIS; CANCER INFILTRATION; CANCER PATIENT; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION TENSOR IMAGING; ECHOMAMMOGRAPHY; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PATIENT INFORMATION; PRIORITY JOURNAL; REVIEW; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 34247501263     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9352-3     Document Type: Review

References (69)

1. Heywang SH, Hahn D, Schmidt H et al (1986) MRI imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10:199-204
2. Bone B, Pentek Z, Perbeck L et al (1997) Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 38:489-496
3. Stomper PC, Winston JS, Herman S et al (1997) Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 45:39-46
4. Boetes C, Barentsz JO, Mus RD et al (1994) MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 193:777-781
5. Heiberg EV, Perman WH, Herrmann VM et al (1996) Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn Reson Imaging 14:337-348
6. Muller-Schimpfle M, Stoll P, Stern W et al (1997) Do mammography, sonography, and MR mammography have a diagnostic benefit compared with mammography and sonography? AJR Am J Roentgenol 168:1323-1329
7. Heywang-Kobrunner SH, Viehweg P, Heinig A et al (1997) Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 24:94-108
8. Morris EA, Schwartz LH, Dershaw DD et al (1997) MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 205:437-440
9. Boetes C, Mus RD, Holland R et al (1995) Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197:743-747
10. Kepple J, Layeeque R, Klimberg VS et al (2005) Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg 190:623-627
11. Rieber A, Merkle E, Bohm W et al (1997) MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 21:773-779
12. Orel SG, Schnall MD, Powell CM et al (1995) Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196:115-122
13. Mumtaz H, Hall-Craggs MA, Davidson T et al (1997) Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169:417-424
14. Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881-888
15. Muuller RD, Barkhausen J, Sauerwein W et al (1998) Assessment of local recurrence after breast-conserving therapy with MRI. J Comput Assist Tomogr 22:408-412
16. Liberman L, Morris EA, Lee MJ et al (2002) Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 179:171-178
17. Siegmann KC, Muller-Schimpfle M, Schick F et al (2002) MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data. AJR Am J Roentgenol 178:1403-1409
18. Elston C, Ellis IO (2000) Assessment of histological grade. In: Elston CW, Ellis IO (eds), Symmets W (Emeritus Editor) The breast, systemic pathology, Col 13. Churchill Livingston, Edinburgh, pp 365-384
19. Walker RA, Camplejohn RS (1986) DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol 150:37-42
20. Bouzubar N, Walker KJ, Griffiths K et al (1989) Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59:943-947
21. Fechner RE (1987) Fibroadenoma and related lesions. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, pp 72-85
22. Tsang WY, Chan JK et al (1996) Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 20:921-943
23. Tse GM, Ma TK, Chu WC et al (2004) Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters. Mod Pathol 17:568-572
24. Nassar H, Qureshi H, Volkanadsay N et al (2006) Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 30:501-507
25. Orel SG, Schnall MD, LiVolsi VA et al (1994) Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 190:485-493
26. Weinreb JC, Newstead G (1995) MR imaging of the breast. Radiology 196:593-610
27. Krecke KN, Gisvold JJ (1993) Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 161:957-960
28. Davis PL, Staiger MJ, Harris KB et al (1996) Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Res Treat 37:1-9
29. Paramagul CP, Helvie MA, Adler DD (1995) Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology 195:231-234
30. Butler RS, Venta LA, Wiley EL et al (1999) Sonographic evaluation of infiltrating lobular carcinoma. AJR Am J Roentgenol 172:325-330
31. Kepple J, Layeeque R, Klimberg VS et al (2005) Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg 190:623-627
32. Boetes C, Veltman J, van Die L et al (2004) The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86:31-37
33. AJCC (2002) Cancer staging handbook, 6th edn. Springer, New York, pp 255-282
34. Qayyum A, Birdwell RL, Daniel BL et al (2002) MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol 178:1227-1232
35. Page DL, Anderson TJ, Sakamoto G (1987) Infiltrating carcinoma: major histological types. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, pp 193-235
36. Bonadonna G, Veronesi U, Brambilla C et al (1990) Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82:1539-1545
37. Calais G, Berger C, Descamps P et al (1994) Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 74:1283-1288
38. Cocconi G, Di Blasio B, Alberti G et al (1984) Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 4:309-313
39. Segel MC, Paulus DD, Hortobagyi GN (1988) Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 169:49-54
40. Partridge SC, Gibbs JE, Lu Y et al (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193-1199
41. Esserman L, Kaplan E, Partridge S et al (2001) MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 8:549-559
42. Delille JP, Slanetz PJ, Yeh ED et al (2003) Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 228:63-69 (Epub 2003 May 29)
43. Yeh E, Slanetz P, Kopans DB, Rafferty E et al (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868-877
44. Dao TH, Rahmouni A, Campana F (1993) Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 187:751-755
45. Wasser K, Sinn HP, Fink C et al (2003) Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 13:1213-1223 (Epub 2002 Nov 30)
46. Elston CW, Ellis IO, Pinder SE (2000) Effects of treatment. In: Elston CW, Ellis IO (eds), Symmets W (Emeritus Editor) The breast, systemic pathology, Col 13. Churchill Livingston, Edinburgh, pp 463-476
47. Knopp MV, Brix G, Junkermann HJ et al (1994) MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 2:633-658
48. Harms SE, Flamig DP, Hesley KL et al (1993) Fat-suppressed three-dimensional MR imaging of the breast. Radiographics 13:247-267
49. Bone B, Aspelin P, Bronge L et al (1996) Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 37:208-213
50. Gilles R, Guinebretiere JM, Lucidarme O et al (1994) Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 191:625-631
51. Boetes C, Strijk SP, Holland R et al (1997) False-negative MR imaging of malignant breast tumors. Eur Radiol 7:1231-1234
52. Teifke A, Hlawatsch A, Beier T, Werner Vomweg T, Schadmand S et al (2002) Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology 224:881-888
53. Ghai S, Muradali D, Bukhanov K et al (2005) Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation. AJR Am J Roentgenol 185:481-487
54. Hansen S, Grabau DA, Sorensen FB et al (2006) The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6:139-146
55. Chhieng DC, Tabbara SO, Marley EF et al (2003) Micro-vessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma. Breast J 9:200-207
56. Morphopoulos G, Pearson M, Ryder WD et al (1996) Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol 180:44-49
57. Komatsu S, Lee CJ, Hosokawa Y, Ichikawa D et al (2004) Comparison of intraductal spread on dynamic contrast-enhanced MRI with clinicopathologic features in breast cancer. Jpn J Clin Oncol 34:515-518
58. Ikeda O, Nishimura R, Miyayama H et al (2004) Magnetic resonance evaluation of the presence of an extensive intraductal component in breast cancer. Acta Radiol 45:721-725
59. Cao Y, Paner GP, Kahn LB et al (2004) Noninvasive carcinoma of the breast: angiogenesis and cell proliferation. Arch Pathol Lab Med 128:893-896
60. Ruiz A, Almenar S, Cerda M et al (2002) Ductal carcinoma in situ of the breast: a comparative analysis of histology, nuclear area, ploidy, and neovascularization provides differentiation between low- and high-grade tumors. Breast J 8:139-144
61. Guidi AJ, Schnitt SJ, Fischer L et al (1997) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 80:1945-1953
62. Weinreb JC, Newstead (1995) G.MR imaging of the breast. Radiology 196:593-610
63. Rubens D, Totterman S, Chacko AK et al (1991) Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast. AJR Am J Roentgenol 157:267-270
64. Kerslake RW, Carleton PJ, Fox JN et al (1995) Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast. Clin Radiol 50:440-454
65. Kuhl CK, Mielcareck P, Klaschik S et al (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211:101-110
66. Matsubayashi R, Matsuo Y, Edakuni G et al (2000) Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 217:841-848
67. Ahlgren J, Risberg B, Villman K et al (2002) Angiogenesis in invasive breast carcinoma - a prospective study of tumour heterogeneity. Eur J Cancer 38:64-69
68. Kato T, Kameoka S, Kimura T et al (2001) Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 70:65-74
69. Santinelli A, Baccarini M, Colanzi P et al (2000) Microvessel quantitation in intraductal and early invasive breast carcinomas. Anal Quant Cytol Histol 22:277-284